SARS-CoV-2 seropositivity and seroconversion in patients undergoing active cancer-directed therapy.
Sun L, Surya S, Goodman NG, Le AN, Kelly G, Owoyemi O, Desai H, Zheng C, DeLuca S, Good ML, Hussain J, Jeffries SD, Kry YR, Kugler EM, Mansour M, Ndicu J, Osei-Akoto A, Prior T, Pundock SL, Varughese LA, Weaver J, Doucette A, Dudek S, Verma SS, Gouma S, Weirick ME, McAllister CM, Bange E, Gabriel P, Ritchie M, Rader DJ, Vonderheide RH, Schuchter LM, Verma A, Maillard I, Mamtani R, Hensley SE, Gross R, Wileyto EP, Huang AC, Maxwell KN, DeMichele A.
Sun L, et al. Among authors: kelly g.
medRxiv [Preprint]. 2021 Jan 16:2021.01.15.21249810. doi: 10.1101/2021.01.15.21249810.
medRxiv. 2021.
PMID: 33469597
Free PMC article.
Updated.
Preprint.